arsenic has been researched along with camptothecin in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bjornsti, MA; Douat-Casassus, C; Montaudon, D; Palle, K; Pourquier, P; Quideau, S; Rivory, LP; Robert, J | 1 |
| Horváth, V; Ondrousková, E; Smarda, J; Soucek, K | 1 |
| Cao, WJ; Li, Q; Wang, Y | 1 |
| Cernelc, P; Podgornik, H; Rebersek, K | 1 |
| Chen, L; Guo, M; Guo, Y; Li, Q; Muhammad, F; Wang, A; Wang, N; Zhao, J; Zhu, G | 1 |
| Bernardi, R; Coltella, N; Ponente, M; Ponzoni, M; Valsecchi, R | 1 |
| Chen, S; Pan, M; Tong, Y; Zhang, L; Zhang, X | 1 |
1 review(s) available for arsenic and camptothecin
| Article | Year |
|---|---|
[Research advance of nanometric traditional Chinese herbal drugs for cancer treatment].
Topics: Arsenic Trioxide; Arsenicals; Camptothecin; Drug Carriers; Drugs, Chinese Herbal; Humans; Nanoparticles; Nanotechnology; Neoplasms; Oxides | 2007 |
6 other study(ies) available for arsenic and camptothecin
| Article | Year |
|---|---|
Inhibition of topoisomerase I cleavage activity by thiol-reactive compounds: importance of vicinal cysteines 504 and 505.
Topics: Arsenicals; Camptothecin; Cysteine; DNA Cleavage; DNA Topoisomerases, Type I; Enzyme Inhibitors; Ethylmaleimide; Humans; Mutagenesis, Site-Directed; Protein Conformation; Sulfhydryl Compounds; Topoisomerase I Inhibitors | 2007 |
Alternative pathways of programmed cell death are activated in cells with defective caspase-dependent apoptosis.
Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Autophagy; Blotting, Western; Camptothecin; Caspases; Cell Line, Transformed; Cell Transformation, Neoplastic; Chickens; Cycloheximide; Genes, myb; Humans; Microscopy, Fluorescence; Necrosis; Oxides; Signal Transduction; U937 Cells | 2008 |
Evaluation of multiple myeloma cell apoptosis in primary bone marrow samples.
Topics: ADP-ribosyl Cyclase 1; Apoptosis; Arsenic Trioxide; Arsenicals; Bone Marrow; Camptothecin; Female; Flow Cytometry; Humans; Immunophenotyping; Male; Multiple Myeloma; Oxides; Syndecan-1 | 2013 |
Lethal drug combination: arsenic loaded multiple drug mesoporous silica for theranostic applications.
Topics: Arsenic Trioxide; Arsenicals; Camptothecin; Contrast Media; Drug Delivery Systems; Oxides; Silicon Dioxide | 2014 |
Synergistic Leukemia Eradication by Combined Treatment with Retinoic Acid and HIF Inhibition by EZN-2208 (PEG-SN38) in Preclinical Models of PML-RARα and PLZF-RARα-Driven Leukemia.
Topics: Animals; Arsenic Trioxide; Arsenicals; Camptothecin; Cell Differentiation; Cell Movement; Disease Models, Animal; Drug Resistance, Neoplasm; Drug Synergism; Gene Expression Regulation, Neoplastic; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Leukemia, Promyelocytic, Acute; Mice; Mutation; Neoplasm Proteins; Oncogene Proteins, Fusion; Oxides; Polyethylene Glycols; Tretinoin | 2015 |
Arsenic sulfide combined with JQ1, chemotherapy agents, or celecoxib inhibit gastric and colon cancer cell growth.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Arsenicals; Azepines; Camptothecin; Celecoxib; Cell Line, Tumor; Cisplatin; Colonic Neoplasms; Drug Synergism; Gene Expression Regulation, Neoplastic; Humans; Irinotecan; p38 Mitogen-Activated Protein Kinases; Stomach Neoplasms; Sulfides; Triazoles; Tumor Suppressor Protein p53 | 2015 |